company background image
MAK logo

Maternus-Kliniken XTRA:MAK Stock Report

Last Price

€2.10

Market Cap

€44.0m

7D

19.3%

1Y

52.2%

Updated

05 Jul, 2024

Data

Company Financials

Maternus-Kliniken Aktiengesellschaft

XTRA:MAK Stock Report

Market Cap: €44.0m

MAK Stock Overview

Operates retirement and nursing homes, rehabilitation clinics, and various service companies that operate in the field of geriatric care and rehabilitation medicine.

MAK fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Maternus-Kliniken Aktiengesellschaft Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Maternus-Kliniken
Historical stock prices
Current Share Price€2.10
52 Week High€4.70
52 Week Low€1.38
Beta0.64
11 Month Change20.69%
3 Month Change2.94%
1 Year Change52.17%
33 Year Change-45.03%
5 Year Change27.27%
Change since IPO-80.79%

Recent News & Updates

Maternus-Kliniken Aktiengesellschaft (ETR:MAK) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable

Jul 05
Maternus-Kliniken Aktiengesellschaft (ETR:MAK) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable

A Piece Of The Puzzle Missing From Maternus-Kliniken Aktiengesellschaft's (ETR:MAK) Share Price

Mar 13
A Piece Of The Puzzle Missing From Maternus-Kliniken Aktiengesellschaft's (ETR:MAK) Share Price

Recent updates

Maternus-Kliniken Aktiengesellschaft (ETR:MAK) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable

Jul 05
Maternus-Kliniken Aktiengesellschaft (ETR:MAK) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable

A Piece Of The Puzzle Missing From Maternus-Kliniken Aktiengesellschaft's (ETR:MAK) Share Price

Mar 13
A Piece Of The Puzzle Missing From Maternus-Kliniken Aktiengesellschaft's (ETR:MAK) Share Price

Maternus-Kliniken (ETR:MAK) Will Be Hoping To Turn Its Returns On Capital Around

Jul 27
Maternus-Kliniken (ETR:MAK) Will Be Hoping To Turn Its Returns On Capital Around

The Returns On Capital At Maternus-Kliniken (ETR:MAK) Don't Inspire Confidence

Feb 22
The Returns On Capital At Maternus-Kliniken (ETR:MAK) Don't Inspire Confidence

Some Investors May Be Worried About Maternus-Kliniken's (ETR:MAK) Returns On Capital

Jul 27
Some Investors May Be Worried About Maternus-Kliniken's (ETR:MAK) Returns On Capital

Estimating The Fair Value Of Maternus-Kliniken Aktiengesellschaft (ETR:MAK)

Jun 10
Estimating The Fair Value Of Maternus-Kliniken Aktiengesellschaft (ETR:MAK)

Shareholder Returns

MAKDE HealthcareDE Market
7D19.3%2.5%0.9%
1Y52.2%4.1%5.7%

Return vs Industry: MAK exceeded the German Healthcare industry which returned 2.7% over the past year.

Return vs Market: MAK exceeded the German Market which returned 6.1% over the past year.

Price Volatility

Is MAK's price volatile compared to industry and market?
MAK volatility
MAK Average Weekly Movement6.4%
Healthcare Industry Average Movement5.2%
Market Average Movement4.7%
10% most volatile stocks in DE Market10.1%
10% least volatile stocks in DE Market2.5%

Stable Share Price: MAK has not had significant price volatility in the past 3 months.

Volatility Over Time: MAK's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
18771,480n/awww.maternus.de

Maternus-Kliniken Aktiengesellschaft operates retirement and nursing homes, rehabilitation clinics, and various service companies that operate in the field of geriatric care and rehabilitation medicine. It also provides emergency call, assisted living, rehabilitation, and follow-up treatment services, as well as domestic, inpatient, short term, and disability care services. The company was founded in 1877 and is headquartered in Berlin, Germany.

Maternus-Kliniken Aktiengesellschaft Fundamentals Summary

How do Maternus-Kliniken's earnings and revenue compare to its market cap?
MAK fundamental statistics
Market cap€44.04m
Earnings (TTM)-€14.26m
Revenue (TTM)€114.94m

0.4x

P/S Ratio

-3.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MAK income statement (TTM)
Revenue€114.94m
Cost of Revenue€90.40m
Gross Profit€24.53m
Other Expenses€38.79m
Earnings-€14.26m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.68
Gross Margin21.35%
Net Profit Margin-12.40%
Debt/Equity Ratio0%

How did MAK perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.